Form 8-K - Current report:
SEC Accession No. 0001193125-24-253747
Filing Date
2024-11-08
Accepted
2024-11-08 08:26:55
Documents
59
Period of Report
2024-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d870301d8k.htm   iXBRL 8-K 56659
2 EX-2.1 d870301dex21.htm EX-2.1 763569
3 EX-10.1 d870301dex101.htm EX-10.1 52673
4 EX-10.2 d870301dex102.htm EX-10.2 54915
5 EX-10.3 d870301dex103.htm EX-10.3 28693
6 EX-99.1 d870301dex991.htm EX-99.1 35433
7 EX-99.2 d870301dex992.htm EX-99.2 55857
11 GRAPHIC g870301ex99_2s10g1.jpg GRAPHIC 108329
12 GRAPHIC g870301ex99_2s11g1.jpg GRAPHIC 96796
13 GRAPHIC g870301ex99_2s12g1.jpg GRAPHIC 73688
14 GRAPHIC g870301ex99_2s13g1.jpg GRAPHIC 79228
15 GRAPHIC g870301ex99_2s14g1.jpg GRAPHIC 110017
16 GRAPHIC g870301ex99_2s15g1.jpg GRAPHIC 86867
17 GRAPHIC g870301ex99_2s16g1.jpg GRAPHIC 75623
18 GRAPHIC g870301ex99_2s17g1.jpg GRAPHIC 26371
19 GRAPHIC g870301ex99_2s18g1.jpg GRAPHIC 73133
20 GRAPHIC g870301ex99_2s19g1.jpg GRAPHIC 78461
21 GRAPHIC g870301ex99_2s1g1.jpg GRAPHIC 131363
22 GRAPHIC g870301ex99_2s20g1.jpg GRAPHIC 88777
23 GRAPHIC g870301ex99_2s21g1.jpg GRAPHIC 27707
24 GRAPHIC g870301ex99_2s22g1.jpg GRAPHIC 72524
25 GRAPHIC g870301ex99_2s23g1.jpg GRAPHIC 75833
26 GRAPHIC g870301ex99_2s24g1.jpg GRAPHIC 74448
27 GRAPHIC g870301ex99_2s25g1.jpg GRAPHIC 116252
28 GRAPHIC g870301ex99_2s26g1.jpg GRAPHIC 73617
29 GRAPHIC g870301ex99_2s27g1.jpg GRAPHIC 67665
30 GRAPHIC g870301ex99_2s28g1.jpg GRAPHIC 72549
31 GRAPHIC g870301ex99_2s29g1.jpg GRAPHIC 95850
32 GRAPHIC g870301ex99_2s2g1.jpg GRAPHIC 247546
33 GRAPHIC g870301ex99_2s30g1.jpg GRAPHIC 92371
34 GRAPHIC g870301ex99_2s31g1.jpg GRAPHIC 28679
35 GRAPHIC g870301ex99_2s32g1.jpg GRAPHIC 80334
36 GRAPHIC g870301ex99_2s33g1.jpg GRAPHIC 99602
37 GRAPHIC g870301ex99_2s34g1.jpg GRAPHIC 55650
38 GRAPHIC g870301ex99_2s35g1.jpg GRAPHIC 25725
39 GRAPHIC g870301ex99_2s36g1.jpg GRAPHIC 65949
40 GRAPHIC g870301ex99_2s37g1.jpg GRAPHIC 126418
41 GRAPHIC g870301ex99_2s38g1.jpg GRAPHIC 104057
42 GRAPHIC g870301ex99_2s39g1.jpg GRAPHIC 127089
43 GRAPHIC g870301ex99_2s3g1.jpg GRAPHIC 72484
44 GRAPHIC g870301ex99_2s40g1.jpg GRAPHIC 32871
45 GRAPHIC g870301ex99_2s4g1.jpg GRAPHIC 104005
46 GRAPHIC g870301ex99_2s5g1.jpg GRAPHIC 76721
47 GRAPHIC g870301ex99_2s6g1.jpg GRAPHIC 110363
48 GRAPHIC g870301ex99_2s7g1.jpg GRAPHIC 74176
49 GRAPHIC g870301ex99_2s8g1.jpg GRAPHIC 29714
50 GRAPHIC g870301ex99_2s9g1.jpg GRAPHIC 96151
  Complete submission text file 0001193125-24-253747.txt   6072531

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA alvr-20241107.xsd EX-101.SCH 2850
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20241107_lab.xml EX-101.LAB 18737
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20241107_pre.xml EX-101.PRE 11707
62 EXTRACTED XBRL INSTANCE DOCUMENT d870301d8k_htm.xml XML 3803
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 241438092
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)